GRAIL Teams with Priority Health to Expand Galleri
MENLO PARK, Calif., July 16, 2026 GRAIL, Inc. has announced a strategic collaboration with Priority Health, making the GalleriĀ®...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MENLO PARK, Calif., July 16, 2026 GRAIL, Inc. has announced a strategic collaboration with Priority Health, making the GalleriĀ®...
BRISBANE, CALIFORNIA, April 28, 2026 CareDx Inc. has announced a definitive agreement to acquire Naveris, marking a significant expansion...
HOUSTON, December 11, 2025 ā Plus Therapeutics announced that its subsidiary CNSide Diagnostics, LLC has secured new state laboratory...
Stockholm ā October 6, 2025. The Nobel Assembly at Karolinska Institutet has awarded the 2025 Nobel Prize in Physiology...
WEST HILLS, Calif., Oct. 8, 2025 ā Thermo Fisher Scientific has introduced the Molecular MicroscopeĀ® Diagnostic System for Lung...
